CD4 and ovarian carcinoma: In the B16‐OVA syngeneic mouse model and ovarian cancer, oncolytic adenoviruses increased the proportion of tumor‐infiltrating CD8+ T cells and CD4+ T cells, leading to significant reduction in tumor growth.31, 32